A

Phase IV adaptive randomised clinical trials evaluating efficacy and cost-efficacy of pre-emptive pharmacogenetic genotyping strategies in the Spanish National Health System: iPHARMGx Master Protocol and PREVESTATGx nested clinical trial

BMJ Open

Authors 0

  1. Author list not loaded yet.

Cited by 0 stored of 4

References 2

2 results